Showing 881-890 of 2050 results for "".
Do You Know the Ocular Effects of HRT?
https://modernod.com/topics/nutritionpharmaceuticals/do-you-know-the-ocular-effects-of-hrt/38534/This review of potential harms and benefits associated with hormone replacement therapy will help you provide the best possible eye care to all patients.Eye Care for Pregnant and Postpartum Patients
https://modernod.com/topics/patient-care/eye-care-for-pregnant-and-postpartum-patients/38533/A guide for identifying eye- and vision-related changes in this population and supporting their needs.Know Your Monoclonal Antibodies
https://modernod.com/topics/nutritionpharmaceuticals/know-your-monoclonal-antibodies/38531/These pharmaceutical agents are used to treat a variety of ocular diseases. Knowing how they’re dosed and their potential side effects will serve you and your patients well.Playing Tricks on the Eyes
https://modernod.com/mod-issues/2022-nov-dec/playing-tricks-on-the-eyes/38530/Using prism can redirect how light hits the retina and improve visual function.The OD’s Function in Retina Surgery
https://modernod.com/topics/retina/the-ods-function-in-retina-surgery/38528/Tips for comanaging patients following vitrectomy from the early postoperative period on.Retina Therapeutic Roundup
https://modernod.com/topics/retina/retina-therapeutic-roundup/38526/An overview of promising new drugs targeting diseases that threaten the sight of our patients.Global Perspectives With Roya Habibi, OD, FAAO, FSLS
https://modernod.com/topics/human-interest/global-perspectives-with-roya-habibi-od-faao-fsls/38525/Reflecting Back, Giving Forward
https://modernod.com/mod-issues/2022-nov-dec/reflecting-back-giving-forward/38522/The Referral Conundrum
https://modernod.com/mod-issues/2022-oct/the-referral-conundrum/39128/When in doubt about a keratoconus suspect, refer them—you could be saving their sight.Correcting High Myopia at the Nodal Point
https://modernod.com/mod-issues/2022-oct/correcting-high-myopia-at-the-nodal-point/39127/Redesigned with a central port, the latest version of the ICL is associated with better visual outcomes and less risk than earlier iterations of the lens.